- 专利标题： TREATMENT AND PREVENTION OF DEVELOPMENTAL DISORDERS AND MENTAL DISEASES
-
申请号： US18569721申请日： 2020-06-13
-
公开(公告)号： US20240277712A1公开(公告)日： 2024-08-22
- 发明人: Kinichi NAKASHIMA , Hideyuki NAKASHIMA , Alysson Renato MUOTRI
- 申请人： KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION , UNIVERSITY OF CALIFORNIA,SAN DIEGO
- 申请人地址： JP CA Fukuoka-shi
- 专利权人： KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 当前专利权人： KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 当前专利权人地址： JP Fukuoka-shi; US CA Oakland
- 优先权： JP 21098585 2021.06.14
- 国际申请： PCT/JP2022/023638 2020.06.13
- 进入国家日期： 2023-12-13
- 主分类号： A61K31/513
- IPC分类号： A61K31/513
摘要：
The present invention aims at therapeutics to treat and/or prevent Rett syndrome (RTT), autism spectrum disorders or schizophrenia for which no curative therapy has yet been found.
The invention relates to pharmaceutical compositions for preventing or treating Rett syndrome (RTT), autism spectrum disorders, or schizophrenia, which comprises a reverse transcription inhibitor for retrotransposon L1.
The invention relates to pharmaceutical compositions for preventing or treating Rett syndrome (RTT), autism spectrum disorders, or schizophrenia, which comprises a reverse transcription inhibitor for retrotransposon L1.
信息查询
IPC分类:
